KK
Kewal Kundanlal Handa
About Kewal Kundanlal Handa
Data last updated:
Kewal Kundanlal Handa is a Director at Poonawalla Fincorp Limited (since 2024), Director at Akums Drugs And Pharmaceuticals Limited (since 2022) and Additional Director at Aster Dm Quality Care Limited (since 2026), and holds 14 more current directorships. The companies operate in Financial Services, Chemicals and Pharma. The 12 current companies with reported revenue have a combined latest revenue of ₹21,142 Cr; the largest is Poonawalla Fincorp Limited at ₹6,796 Cr (FY 2026). Earlier, Kewal Kundanlal Handa was a Director Appointed In Casual Vacancy at Sudarshan Colorants India Limited (2015–2016) and Managing Director at Pfizer Limited (1996–2012) and 17 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Poonawalla Fincorp Limited L51504PN1978PLC209007 | Director | 01 Oct 2024 | 1978 | ₹6,796 Cr (FY 2026) | Active |
 Akums Drugs And Pharmaceuticals Limited L24239DL2004PLC125888 | Director | 16 Mar 2022 | 2004 | ₹4,488 Cr (FY 2026) | Active |
 Aster Dm Quality Care Limited L85110TS2008PLC207383 | Additional Director | 01 Jul 2026 | 2008 | ₹4,287 Cr (FY 2025) | Active |
 Wellness Forever Medicare Limited U24239MH2008PLC178658 | Director | 01 Sep 2021 | 2008 | ₹1,673 Cr (FY 2026) | Active |
 Quality Care India Limited U85110TG1992PLC014728 | Director | 23 Jul 2024 | 1992 | ₹1,624 Cr (FY 2023) | Active |
 Borosil Limited L36100MH2010PLC292722 | Director | 03 Feb 2020 | 2010 | ₹1,226 Cr (FY 2026) | Active |
 Sael Industries Limited U40106PB2022PLC055755 | Director | 29 Jul 2025 | 2022 | ₹731 Cr (FY 2025) | Active |
 United Ciigma Institute Of Medical Sciences Private Limited U74120MH2011PTC213136 | Director | 23 Mar 2023 | 2011 | ₹147 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sudarshan Colorants India Limited L24110MH1956PLC010806 | Director Appointed In Casual Vacancy | 05 Nov 2015 | 1956 | ₹844 Cr (FY 2025) | Active |
 Pfizer Limited L24231MH1950PLC008311 | Managing Director | 16 Dec 1996 | 1950 | ₹2,454 Cr (FY 2025) | Active |
 Borosil Renewables Limited L26100MH1962PLC012538 | Additional Director | 30 Aug 2018 | 1962 | ₹1,515 Cr (FY 2025) | Active |
 R M Drip And Sprinklers Systems Limited L27200MH2004PLC150101 | Additional Director | 28 Jun 2017 | 2004 | ₹131 Cr (FY 2025) | Active |
 Wyeth Limited L85190MH1947PLC005963 | Managing Director | 26 Oct 2009 | 1947 | Amalgamated | |
 Mukta Arts Limited L92110MH1982PLC028180 | Additional Director | 07 Jun 2014 | 1982 | ₹180 Cr (FY 2025) | Active |
 Greaves Cotton Limited L99999MH1922PLC000987 | Additional Director | 06 May 2016 | 1922 | ₹2,973 Cr (FY 2025) | Active |
 Infiiloom India Private Limited U17118PN1995PTC018285 | Additional Director | 29 Oct 2020 | 1995 | ₹396 Cr (FY 2025) | Active |
 Ing Vysya Bank Limited L85110KA1930PLC000124 | Additional Director | 12 Aug 2014 | 1930 | ₹2,262 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kewal Kundanlal Handa
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kewal Kundanlal Handa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kewal Kundanlal Handa
Kewal Kundanlal Handa currently holds 17 directorships: Poonawalla Fincorp Limited (Director, since 01 Oct 2024, revenue ₹6,796 Cr (FY 2026)); Akums Drugs And Pharmaceuticals Limited (Director, since 16 Mar 2022, revenue ₹4,488 Cr (FY 2026)); Aster Dm Quality Care Limited (Additional Director, since 01 Jul 2026, revenue ₹4,287 Cr (FY 2025)); Wellness Forever Medicare Limited (Director, since 01 Sep 2021, revenue ₹1,673 Cr (FY 2026)); Quality Care India Limited (Director, since 23 Jul 2024, revenue ₹1,624 Cr (FY 2023)); and 12 more.
Kewal Kundanlal Handa was first appointed on 16 Dec 1996 as Managing Director at Pfizer Limited. The most recent appointment on record is 01 Jul 2026 at Aster Dm Quality Care Limited.
The 12 current companies of Kewal Kundanlal Handa that report revenue have a combined latest revenue of ₹21,142 Cr: Poonawalla Fincorp Limited ₹6,796 Cr (FY 2026); Akums Drugs And Pharmaceuticals Limited ₹4,488 Cr (FY 2026); Aster Dm Quality Care Limited ₹4,287 Cr (FY 2025); Wellness Forever Medicare Limited ₹1,673 Cr (FY 2026); Quality Care India Limited ₹1,624 Cr (FY 2023); and 7 more.
Kewal Kundanlal Handa held 19 earlier board appointments: Sudarshan Colorants India Limited (Director Appointed In Casual Vacancy, 05 Nov 2015 to 01 Apr 2016); Pfizer Limited (Managing Director, 16 Dec 1996 to 15 Aug 2012); Borosil Renewables Limited (Additional Director, 30 Aug 2018 to 25 Mar 2019); R M Drip And Sprinklers Systems Limited (Additional Director, 28 Jun 2017 to 10 Jul 2017); Wyeth Limited (Managing Director, 26 Oct 2009 to 15 Aug 2012); and 14 more.
The current boards of Kewal Kundanlal Handa's companies include Adar Cyrus Poonawalla (Poonawalla Fincorp Limited), Arvind Ravinder Kapil (Poonawalla Fincorp Limited), Arvind Ravinder Kapil (Poonawalla Fincorp Limited), Kemisha Soni (Poonawalla Fincorp Limited), Prabhakar Ramchandra Dalal (Poonawalla Fincorp Limited), Rajeev Sardana (Poonawalla Fincorp Limited), among others.